Trial Profile
Comparison of the efficacy of palonosetron, with and without dexamethasone, for the prevention of postoperative nausea and vomiting in high-risk patients undergoing laparoscopic bariatric surgeries.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Oct 2011
Price :
$35
*
At a glance
- Drugs Palonosetron (Primary) ; Dexamethasone
- Indications Nausea and vomiting
- Focus Therapeutic Use
- 21 Oct 2011 New trial record
- 19 Oct 2011 Results presented at the 2011 Annual Meeting of the American Society of Anesthesiologists.